GENELUX Corp (GNLX) stock
GNLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.00+0.08 (+4.17%)
Close on Nov 17, 2026Market cap $90.49MP/E –Yield –
Genelux total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Genelux's total debt was $900.00K at Dec 31, 2023. For fiscal 2023 it was $900.00K.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $900.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | $900.00K | – |
| Q3 FY2023 | Sep 30, 2023 | $900.00K | – |
| Q2 FY2023 | Jun 30, 2023 | $900.00K | – |
| Q1 FY2023 | Mar 31, 2023 | $900.00K | – |
See a number that looks wrong?